Return on average equity - 5 year average | 9.23 |
Net Income/employee - trailing 12 month | 21,02,107.00 |
Revenue/employee - most recent fiscal year | 1,11,10,300.00 |
Return on investment - most recent fiscal year | 15.99 |
Return on average assets - most recent fiscal year | 11.37 |
Receivables turnover - most recent fiscal year | 4.00 |
Return on investment - trailing 12 month | 14.92 |
Return on average assets - trailing 12 month | 11.20 |
Inventory turnover - most recent fiscal year | 1.23 |
Inventory turnover - trailing 12 month | 1.07 |
Revenue/employee - trailing 12 month | 1,12,93,880.00 |
Return on average assets - 5 year average | 6.31 |
Net Income/employee - most recent fiscal year | 21,67,301.00 |
Return on average equity - trailing 12 month | 15.14 |
Receivables turnover - trailing 12 month | 3.94 |
Asset turnover - most recent fiscal year | 0.58 |
Asset turnover - trailing 12 month | 0.60 |
Return on average equity - most recent fiscal year | 16.29 |
Return on investment - 5 year average | 9.02 |
Sun Pharmaceutical Industries Dividend | Sun Pharmaceutical Industries Bonus | Sun Pharmaceutical Industries News | Sun Pharmaceutical Industries AGM | Sun Pharmaceutical Industries Rights | Sun Pharmaceutical Industries Splits | Sun Pharmaceutical Industries Board Meetings | Sun Pharmaceutical Industries Shareholdings | Sun Pharmaceutical Industries Profit Loss | Sun Pharmaceutical Industries Balance Sheet | Sun Pharmaceutical Industries Cashflow | Sun Pharmaceutical Industries Q1 Results | Sun Pharmaceutical Industries Q2 Results | Sun Pharmaceutical Industries Q3 Results | Sun Pharmaceutical Industries Q4 Results
Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks